Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Search by expertise, name or affiliation
Mycophenolate mofetil therapy in lupus nephritis: Clinical observations
Mary Anne Dooley
, Fernando G. Cosio
,
Patrick H. Nachman
, Michael E. Falkenhain
, Susan L. Hogan
, Ronald J. Falk
, Lee A. Hebert
Research output
:
Contribution to journal
›
Article
›
peer-review
229
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Mycophenolate mofetil therapy in lupus nephritis: Clinical observations'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Mycophenolate Mofetil
100%
Lupus Nephritis
100%
Clinical Observation
100%
Leukopenia
33%
Pancreatitis
22%
Cyclophosphamide
22%
Adverse Events
22%
Controlled Experiment
22%
Serum Creatinine
22%
Nephritis
22%
Diarrhea
11%
Pneumonia
11%
Previously Treated
11%
Proteinuria
11%
Herpes Simplex
11%
Initial Treatment
11%
Renal Transplantation
11%
Clinical Experience
11%
Systemic Lupus Erythematosus
11%
Scalp Hair
11%
Duration of Therapy
11%
Dose Reduction
11%
Renal Manifestations
11%
Rejection Rate
11%
Nausea
11%
Complement C3
11%
Prednisone Therapy
11%
Initial Dose
11%
Antibody Level
11%
Stomatitis
11%
Protein-to-creatinine Ratio
11%
Anti-double-stranded DNA Antibodies
11%
Serum Complement
11%
Renal Transplant Rejection
11%
Medicine and Dentistry
Mycophenolate Mofetil
100%
Clinical Observation
100%
Lupus Nephritis
100%
Creatinine
33%
Leukopenia
33%
Pancreatitis
22%
Adverse Event
22%
Cyclophosphamide
22%
Controlled Clinical Trial
22%
Nephritic Syndrome
22%
Kidney Transplantation
11%
Diarrhea
11%
Recurrent Disease
11%
Proteinuria
11%
Scalp Hair
11%
Azathioprine
11%
Nausea
11%
Complement Component C3
11%
Complement
11%
Drug Dose Reduction
11%
Treatment Duration
11%
Kidney Graft Rejection
11%
Double Stranded DNA Antibody
11%
Herpetic Stomatitis
11%
Prednisone
11%
Systemic Lupus Erythematosus
11%
Immunology and Microbiology
Lupus Erythematosus
100%
Nephritis
100%
Mycophenolate Mofetil
100%
Creatinine Blood Level
22%
Cyclophosphamide
22%
Pancreatitis
22%
Systemic Lupus Erythematosus
11%
Complement Component 3
11%
Herpes Simplex
11%
Prednisone
11%
Scalp Hair
11%
Drug Dose Reduction
11%
Azathioprine
11%
Complement
11%
Kidney Graft Rejection
11%
Protein Urine Level
11%
Double Stranded DNA Antibody
11%
Kidney Transplantation
11%
Noma
11%
Pharmacology, Toxicology and Pharmaceutical Science
Mycophenolate Mofetil
100%
Lupus Erythematosus Nephritis
100%
Creatinine
33%
Leukopenia
33%
Controlled Clinical Trial
22%
Cyclophosphamide
22%
Adverse Event
22%
Nephritis
22%
Pancreatitis
22%
Diarrhea
11%
Azathioprine
11%
Recurrent Disease
11%
Nausea
11%
Complement Component C3
11%
Complement
11%
Kidney Graft Rejection
11%
Double Stranded DNA Antibody
11%
Herpetic Stomatitis
11%
Proteinuria
11%
Prednisone
11%
Systemic Lupus Erythematosus
11%